Chapter 35
Lecture 11
Drugs for Common Upper
Respiratory Infections
Respiratory Tract
• Upper respiratory tract
includes: nares, nasal
cavity, pharynx, and
larynx.
• Lower respiratory tract
includes: trachea,
bronchi, bronchioles,
alveoli, and alveolar-
capillary membrane
• Air enters the upper
resp. tract & travels to
the lower tract where
gas exchange takes
place
Respiratory Tract
• Respiration = the process whereby gas exchange occurs at
the alveolar-capillary membrane. 3 phases:
1. Ventilation - movement of air from the atmosphere
through the upper & lower airways to the alveoli
2. Perfusion - blood from the pulmonary circulation is
adequate at the alveolar-capillary bed
3. Diffusion - molecules move from area of higher
concentration to lower concentration of gases - O2 passes
into the capillary bed to be circulated & CO2 leaves the
capillary bed & diffuses into the alveoli for vent. excretion
Respiratory Tract
• Perfusion - influenced by alveolar pressure. For gas
exchange, the perfusion of each alveoli must be matched
by adequate ventilation. Mucosal edema, secretions, &
bronchospasms increase the resistance to airflow & dec.
ventilation & diffusion of gases
• Bronchial Smooth Muscle - In the tracheobronchial tube is
smooth muscle whose fibers spiral around the tube 
contraction  constriction of airway
- Parasympathetic Nervous system  releases acetylcholine
 bronchoconstriction
- Sympathetic Nervous system  releases epinephrine 
stimulates beta-2 receptors in bronchial smooth muscle 
bronchodilation
Drugs for Upper respiratory
Infections
• Upper Respiratory Infections (URI’s) = common cold,
acute rhinitis, sinusitis, acute tonsillitis, acute laryngitis
- The common cold = most expensive > $500 million
spent on OTC preparations
• Common Cold & Acute Rhinitis -
- Common cold caused by the rhinovirus & affects
primarily the nasopharyngeal tract.
- Acute rhinitis (inflammation of mucus membranes of
nose) usually accompanies the common cold
- Allergic rhinitis - caused by pollen or a foreign substance
Drugs for Upper Respiratory
Infections
• Incubation period of a cold = 1 to 4 days before
onset of symptoms & first 3 days of the cold
- Home remedies = rest, chicken soup, hot toddies,
Vitamins
- 4 groups of drugs used to manage symptoms =
antihistamins (H-1 blocker), decongestants
(sympathomimetic amines), antitussives,
expectorants
Drugs for Upper Respiratory
Infections - Antihistamines
• Antihistamines or H-1 blockers - compete w/ histamine for
receptor sites  prevents a histamine response.
2 types of histamine receptors - H-1 & H-2
H-1 stimulation = extravascular smooth muscles
(including those lining nasal cavity) are constricted
H-2 stimulation = an inc. in gastric secretions = peptic
ulcer disease
Do not confuse the 2 receptors - antihistamines decrease
nasopharyngeal secretions by blocking the H-1 receptor
Drugs for Upper Respiratory
Infections - antihistamines
• Histamines - A compound derived from an amino acid
histadine. Released in response to an allergic rxn (antigen-
antibody rxn) - such as inhaled pollen
- When released it reacts w/ H-1 receptors = arterioles &
capillaries dialate = inc. in bld flow to the area =
capillaries become more permeable = outward passage of
fluids into extracellular spaces= edema (congestion) =
release of secretions (runny nose & watery eyes)
- Large amts. of released histamine in an allergic rxn =
extensive arteriolar dilation = dec. BP, skin flushed &
edematous = itching, constriction & spasm of bronchioles
= SOB & lg. amts. of pulmonary & gastric secretions
Drugs for Upper Respiratory
Infections - Antihistamines
• Astemizole (Hismanal), Cetirizine (Zertec), Loratadine
(Claritin), Chlorpheniramine (Chlortrimeton),
Diphenhydramine (Benadryl)
• Actions = competitive antagonist at the histamine
receptor; some also have anticholinergic properties
• Uses = Treat colds; perennial/seasonal allergic rhinitis
(sneezing, runny nose); allergic activity (drying &
sedation); some are also antiemetic
• SE = Drowsiness, dizziness, sedation, drying effects
• CI = glaucoma, acute asthma
Drugs for Upper Respiratory
Infections - Decongestants
• Nasal congestion results from dilation of nasal bld.
vessels d/t infection, inflammation, or allergy.
With dilation there’s transudation of fluid into
tissue spaces  swelling of the nasal cavity
• Decongestants (sympathomimetic amines)
- stimulate alpha-adrenergic receptor 
vasoconstriction of capillaries w/in nasal mucosa
 shrinking of the nasal mucus membranes &
reduction in fluid secretion (runny nose)
Drugs for Upper Respiratory
Infections - Decongestants
• Naphazoline HCL (Allerest), Pseudoephedrine
(Actifed, Sudafed), Oxymetolazone (Afrin),
Phenylpropanolamine HCL (Allerest, Dimetapp)
• Use - Congestion d/t common cold, hayfever, upper resp.
allergies, sinusitis
• SE = Jittery,nervous,restless, Inc BP, inc. bld. sugar
• CI = Hypertension, cardiac disease, diabetes
• Preparations = nasal spray, tablets, capsules, or liquid
• Frequent use, esp. nasal spray, can result in tolerance &
rebound nasal congestion - d/t irritation of nasal mucosa
Drugs for Upper Respiratory Infections -
Intranasal Glucocorticoids
• Beclomethasone (Beconase, Vancenase, Vanceril),
Budesonide (Rhinocort), Dexamethasone
(Decadron)fluticasone (Flonase)
- Action - steroids used to dec. inflammation locally in the
nose
- Use - Perennial/seasonal allergic rhinitis (sneezing, runny
nose) - May be used alone or w/ antihistamines
- SE - rare, but w/ continuous use dryness of the nasal
mucosa may occur
Drugs for Upper Respiratory
Infections - Antitussives
• Action - Acts on the cough control center in the medulla to
suppress the cough reflex
• Use - Cough suppression for non-productive irritating
coughs
* Codeine - Narcotic analgesic to control a cough d/t the
common cold or bronchitis
* Dextromethorphan - nonnarcotic antitussive that
suppresses the cough center in the medulla, widely used
- syrup, liquid, chewable & lozenges
- SE = drowsiness, sedation
Drugs for Upper Respiratory
infections - Expectorants
• Action - Loosens bronchial secretions so they can
be eliminated w/ coughing
* A nonproductive cough becomes more
productive and less frequent
• Uses - Nonproductive coughs
• Guaifenesin (Robitussin) = Most common
* Use alone or in combo w/ other resp. drugs
• Hydration is the best expectorant
Chapter 36
Drugs for Acute and Chronic
Lower Respiratory Disorders
Drugs for Lower Respiratory
Disorders
• Lung Compliance - Lung volume based on the unit of
pressure in the alveoli
* Determines the lung’s ability to stretch (tissue elasticity)
* Determined by: connective tissue; surface tension in the
alveoli controlled by surfactant
- surfactant lowers surface tension in alveoli & prevents
interstitial fluid from entering
* Inc. (high) lung compliance in COPD
* Dec. (low) lung compliance in restrictive pulmonary
disease = lungs become “stiff” & need more pressure
Drugs for Lower Respiratory
Disorders
• Chronic obstructed pulmonary disease (COPD) &
restrictive pulmonary disease = 2 major lower resp. tract
diseases
• COPD = airway obstruction w/ inc. airway resistance to
airflow to lung tissues - 4 causes
- Chronic bronchitis - emphysema
- Bronchiectasis - asthma
* Above frequently result in irreversible lung tissue
damage. Asthma reversible unless frequent attacks and
becomes chronic.
Drugs for Lower Respiratory
Disorders
• Restrictive lung disease = a dec. in total lung
capacity as a result of fluid accumulation or loss of
elasticity of the lung.
* Causes: Pulmonary edema, pulmonary fibrosis,
pneumonitis, lung tumors, scoliosis
• Bronchial Asthma = 10-12 million people of all
ages affected - a chronic obstructive pulmonary
disease characterized by periods of bronchospasm
resulting in wheezing & difficulty in breathing
Drugs for Lower Respiratory
Disorders
• Asthma - Bronchospasm or bronchoconstriction results
when the lung tissue is exposed to extrinsic or intrinsic
factors that stimulate a bronchoconstrictive response
- Causes: humidity, air pressure changes, temp. changes,
smoke, fumes, stress, emotional upset, allergies, dust,
food, some drugs
* Pathophys = Mast cells (found in connective tissue
throughout the body) are directly involved in the asthmatic
response - esp. to extrinsic factors
- allergens attach themselves to mast cells & basophils =
antigen-antibody rxn
Drugs for Lower Respiratory
Disorders - Asthma
• Mast cells stimulate release of chemical mediators
(histamines, cytokines, serotonin, ECF-A (eosinophils))
• These chemical mediators stimulate bronchial constriction,
mucous secretions, inflammation, pulmonary congestion
• Cyclic adenosine monophosphate (cAMP) - a cellular
substance responsible for maintaining bronchodilation -
When inhibited by histamines & ECF-A  bronchoconst.
• Sympathomimetic (adrenergic) bronchodilators inc. amt.
of cAMP & promote dilation  first line drugs used
Drugs for Lower Respiratory
Disorders
• Sympathomimetics: Alpha & Beta-2 Adrenergic
Agonists
• Increase cAMP  dilation of bronchioles in acute
bronchospasm caused by anaphylaxis from allergic rxn
give nonselective epinephrine (Adrenalin) - SQ in an
emergency to promote bronchodilation & inc. BP
SE = tremors, dizziness, HTN, tachycardia, heart
palpitations, angina
• For bronchospasm d/t COPD - selective beta-2 adrenergic
agonists are given via aerosol or tablet
Drugs for Lower Respiratory
Disorders
• Metaproterenol (Alupent, Metaprel) - some beta-1, but
primarily used as a beta-2 agent - PO or inhaler/nebulizer
- For long-term asthma Rx beta-2 adrenergic agonists
frequently given by inhalation
* more drug delivered directly to constricted bronchial
site
* Effective dose less than PO dose & less side effects
- Action = relaxes bronchial smooth muscle - onset = fast
- SE = Nervousness, tremors, restlessness, insomnia & inc.
HR
Drugs for Lower Respiratory
Disorders
• Albuterol (Proventil, Ventolin) - More beta-2 selective
- PO or inhaler
- Used for acute/chronic asthma
- Rapid onset of action & longer duration than
Metaproterenol
- Fewer SE because more beta-2 specific, but high doses
can still effect beta-1 receptors & cause nervousness,
tremors & inc. pulse rate
Drugs for Lower Respiratory
Disorders - Anticholinergics
• Ipratropium bromide (Atrovent) -
- Action - competitive antagonist (inhibits) of cholinergic
receptors in bronchial smooth muscle = bronchiole dilation
- Inhaler
- Use - In combination w/ beta agonist for asthma & for
bronchospasm associated w/ COPD
- Need to teach clients how to use properly: If using
Atrovent w/ a beta-agonist, use beta-agonist 5 min. before
Atrovent; If using Atrovent w/ an inhaled steroid or
cromolyn, use Atrovent 5 min. before the steroid or
cromolyn - bronchioles dilate & drugs more effective
Drugs for Lower Respiratory
Disorders - Methylxanthine derivatives
• Aminophylline, Theophylline (TheoDur), Caffeine –
* PO or IV -
* Use - Treatment of asthma & COPD
* Action - Inc. cAMP  bronchodilation; also - diuresis,
cardiac, CNS & gastric acid stimulation
* When given IV  a low therapeutic index & range -
Monitor levels frequently
* PO doses can be given in standard dosages
* Avoid smoking, caffeine & inc. fluid intake
Methylxanthine derivatives
• Drug Interactions: Inc the risk of dig toxicity, decreases the
effects to lithium,dec theophyllin levels with Dilantin,
theophyllin and beta-adrenergic agonist given together -
synergistic effect can occurcardiac dysrhythmias. Beta
blockers, Tagamet, Inderal and e-mycin decrease the liver
metabolism rate and inc. the half-life and effects of theophyllin
• SE : Anorexia, N&V, nervousness, dizziness, palpitations, GI
upset & bleeding, HA, restlessness, flushing, irritability,
marked hypotension, hyper-reflexia and seizures.
• CI: Severe cardiac dysrhythmias, hyperthyroidism, peptic
ulcer disease (increases gastric secretions)
Drugs for Lower Respiratory Disorders -
Leukotrine Receptor Antagonists & Synthesis
Inhibitors
• Leukotriene (LT) a chemical mediator that can cause
inflammatory changes in the lung. The group cysteinyl
leukotrienes promotes and inc in eosinophil migration,
mucus production, and airway wall edema, which result
in broncho-constriction.
• LT receptor antagonists & LT synthesis inhibitors
(Leukotriene modifiers) effective in reducing the
inflammatory symptoms of asthma triggered by allergic
& environmental stimuli - Not for acute asthma
Leucotriene receptor antagonist and synthesis
inhibitors
•Zafirlukast (Accolate), Zileuton (Zyflo), Montelukast
sodium (Singulair) – PO
• Action - Decreases the inflammatory process Use -
prophylactic & maintenance drug therapy for asthma
•Accolate – 1st
in group, leukotriene receptor antagonist
reduce inflammation & dec bronchoconstriction, PO-
BID-rapidly absorbed
•Singulair –New leukotriene receptor antagonist, short
t1/2 (2.5-5.5) Safe for children under 6yo.
Drugs for Lower Respiratory
Disorders - Glucocorticoids (Steroids)
• Glococorticoids have an anti-inflammatory action and are
used if asthma is unresponsive to bronchodilator therapy
• Given: inhaler- beclomethasone (Vanceril, Beclovent);
tablet - triamcinolone (Amcort, Aristocory),
dexamethasone (Decadron), prednisone; injection -
dexamethasone, hydrocortisone
• SE significant w/ long-term oral use - fluid retention,
hyperglycemia, impaired immune response
• Irritating to the gastric mucosa - take w/ food
• When d/c’ing taper the dosage slowly
Drugs for Lower Respiratory
Disorders - Cromolyn & Nedocromil
• Cromolyn (Intal) - for prophylactic Rx of bronchial
asthma & must be taken on a daily basis - NOT used for
acute asthma - Inhaler
* Action - inhibits the release of histamine that can cause an
asthma rxn
* SE - mouth irritation, cough & a bad taste in the mouth
** Caution - rebound bronchospasm is a serious side effect
do not d/c the drug abruptly
• Nedocromil sodium - action & uses similar to Intal -
prophylactic usage - inhalation therapy - may be more
effective than Intal
Drugs for Lower Respiratory
Disorders - Mucolytics
• Acetylcysteine (Mucomyst) - nebulization
* Action - liquefies & loosens thick mucous secretions so
they can be expectorated
* Use - dissolves thick mucous, acetaminophen overdose
(bonds chemically to reduce liver damage)
* SE - N & V, chest tightness, bronchoconstriction
* Use w/ a bronchodilator
• Dornase alfa (Pulmozyme) - an enzyme that digests the
DNA in thick sputum of cystic fibrosis (CF) clients
MATH
NDC 000w-7293-01 VIAL No. 7293
R/X Lilly
ADD-Vantage Vial
NEBCIN
Tobramycin
sulfate injection,
usp
60 Mg per 6ml
You need to prepare 30 mg. How
much solution will you need?
30 mg X 6 ml =
60 mg
1 X 6 ml =
2
6 = 3 ml
2

More Related Content

PPT
Pharmacolog Bronchopulmonary systems.ppt
PPT
Drugs affecting respiratory system
PPTX
UNIT-6(A)Respiratory drugs.pptx pharmacology
PPT
Drugs Affecting Respiratory System
PPTX
unit 06 (A) Respiratory drugs UNIT.pptxj
PPTX
Respiratory drugs and its side effects And uses
ODP
Drugs affecting respiratory system
PPT
DRUGS USED IN THE RESPIRATORY SYSTEM - Copy - Copy - Copy.ppt
Pharmacolog Bronchopulmonary systems.ppt
Drugs affecting respiratory system
UNIT-6(A)Respiratory drugs.pptx pharmacology
Drugs Affecting Respiratory System
unit 06 (A) Respiratory drugs UNIT.pptxj
Respiratory drugs and its side effects And uses
Drugs affecting respiratory system
DRUGS USED IN THE RESPIRATORY SYSTEM - Copy - Copy - Copy.ppt

Similar to Medications for Common URTIs & LRTIS.ppt (20)

PPT
Drugs acting on respiratory system
PPTX
Respiratory Drugs final.pptx
PPT
DRUGS ACTING ON THE RESPIRATORY SYSTEM - Copy.ppt
PPT
Antihistamines09.ppt
PPT
Respi drugs
PPT
Pharmacology Respiratory Drugs
PPT
Pharmacology Respiratory Drugs
PPT
59292911-Pharmacology-Respiratory-Drugs.ppt
PPTX
pharma_2012_respiratory_drugs_b (1).pptx
PPTX
PHARMA- DRUGS FOR RESPIRATORY DISORDERS
PPT
Respiratoy drugs outline
PPTX
Drugs acting on respiratory system
PPT
Ppt respiratory system
PPTX
drugs-affecting-respiratory-system..pptx
PPTX
Respiratory drugs
PPTX
Respiratory system
PDF
drugs for respiratory for PCL Nursing
PPT
NurseReview.Org - Antihistamines (Clinical Pharmacology)
PPTX
Pharmacology of Respiratory System.pptx
PPTX
Respiratory Drugs.pptx
Drugs acting on respiratory system
Respiratory Drugs final.pptx
DRUGS ACTING ON THE RESPIRATORY SYSTEM - Copy.ppt
Antihistamines09.ppt
Respi drugs
Pharmacology Respiratory Drugs
Pharmacology Respiratory Drugs
59292911-Pharmacology-Respiratory-Drugs.ppt
pharma_2012_respiratory_drugs_b (1).pptx
PHARMA- DRUGS FOR RESPIRATORY DISORDERS
Respiratoy drugs outline
Drugs acting on respiratory system
Ppt respiratory system
drugs-affecting-respiratory-system..pptx
Respiratory drugs
Respiratory system
drugs for respiratory for PCL Nursing
NurseReview.Org - Antihistamines (Clinical Pharmacology)
Pharmacology of Respiratory System.pptx
Respiratory Drugs.pptx
Ad

More from AshwaniSood12 (20)

PPTX
NEONATAL -PRIMITIVE -REFLEXES- Evaluation and Clinical Interpretation.pptx
PPTX
URINARY TRACT INFECTIONS in CHILDREN -Prevention & Management.pptx
PPTX
Megaloblastic Anemia in Children and.pptx
PPTX
Malabsorption in children -what's new .pptx
PPTX
IRON DEFICIENCY ANEMIA -THALASSEMIA.pptx
PPTX
The Diagnosis and Treatment of Iron Deficiency in Primary Care.pptx
PPTX
Breastfeeding & Complementary Feeding as a Strategy to Reduce Child deaths.pptx
PPTX
BREAST FEEDING- The Best Ever Feeding for The Babies.pptx
PPTX
Diagnosis & Mx of CONGENITAL SYPHILIS.pptx
PPTX
Syphilis in Neonates and Infants.pptx
PPTX
Practical APPROACH to Diagnose ANEMIA in CHILDREN .pptx
PPT
Lactation -Physiology and Its Importanve in IYCF .ppt
PPT
Breast Feeding-Issues and Support in US .ppt
PPTX
Chemoprophylaxis in Malaria and approaches smc and nutrition.pptx
PPT
Breast Milk Composition in Human and Its Importance.ppt
PPT
Breast Feeding and Prevention of Infection.ppt
PPT
Iron deficiency Anemia and recommended HEMATINICS for management.ppt
PPTX
Hematopoietic Agents & Erythropoietin.pptx
PPTX
Basics of Physiology of Lactation and .pptx
PPTX
How to Improve Infant and Young Child Feeding...pptx
NEONATAL -PRIMITIVE -REFLEXES- Evaluation and Clinical Interpretation.pptx
URINARY TRACT INFECTIONS in CHILDREN -Prevention & Management.pptx
Megaloblastic Anemia in Children and.pptx
Malabsorption in children -what's new .pptx
IRON DEFICIENCY ANEMIA -THALASSEMIA.pptx
The Diagnosis and Treatment of Iron Deficiency in Primary Care.pptx
Breastfeeding & Complementary Feeding as a Strategy to Reduce Child deaths.pptx
BREAST FEEDING- The Best Ever Feeding for The Babies.pptx
Diagnosis & Mx of CONGENITAL SYPHILIS.pptx
Syphilis in Neonates and Infants.pptx
Practical APPROACH to Diagnose ANEMIA in CHILDREN .pptx
Lactation -Physiology and Its Importanve in IYCF .ppt
Breast Feeding-Issues and Support in US .ppt
Chemoprophylaxis in Malaria and approaches smc and nutrition.pptx
Breast Milk Composition in Human and Its Importance.ppt
Breast Feeding and Prevention of Infection.ppt
Iron deficiency Anemia and recommended HEMATINICS for management.ppt
Hematopoietic Agents & Erythropoietin.pptx
Basics of Physiology of Lactation and .pptx
How to Improve Infant and Young Child Feeding...pptx
Ad

Recently uploaded (20)

PDF
Adverse drug reaction and classification
PPT
Infections Member of Royal College of Physicians.ppt
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
Mitral Stenosis in Pregnancy anaesthesia considerations.pptx
PPT
Rheumatology Member of Royal College of Physicians.ppt
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PPTX
Wheat allergies and Disease in gastroenterology
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PDF
Forensic Psychology and Its Impact on the Legal System.pdf
PPT
Blood and blood products and their uses .ppt
PDF
New-Child for VP Shunt Placement – Anaesthetic Management - Copy (1).pdf
PDF
Nursing manual for conscious sedation.pdf
PPT
Dermatology for member of royalcollege.ppt
PDF
Gynecologic Malignancies.Dawit.pdf............
PPTX
Impression Materials in dental materials.pptx
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
Adverse drug reaction and classification
Infections Member of Royal College of Physicians.ppt
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Mitral Stenosis in Pregnancy anaesthesia considerations.pptx
Rheumatology Member of Royal College of Physicians.ppt
OSCE Series Set 1 ( Questions & Answers ).pdf
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
Wheat allergies and Disease in gastroenterology
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
neurology Member of Royal College of Physicians (MRCP).ppt
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
Forensic Psychology and Its Impact on the Legal System.pdf
Blood and blood products and their uses .ppt
New-Child for VP Shunt Placement – Anaesthetic Management - Copy (1).pdf
Nursing manual for conscious sedation.pdf
Dermatology for member of royalcollege.ppt
Gynecologic Malignancies.Dawit.pdf............
Impression Materials in dental materials.pptx
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...

Medications for Common URTIs & LRTIS.ppt

  • 1. Chapter 35 Lecture 11 Drugs for Common Upper Respiratory Infections
  • 2. Respiratory Tract • Upper respiratory tract includes: nares, nasal cavity, pharynx, and larynx. • Lower respiratory tract includes: trachea, bronchi, bronchioles, alveoli, and alveolar- capillary membrane • Air enters the upper resp. tract & travels to the lower tract where gas exchange takes place
  • 3. Respiratory Tract • Respiration = the process whereby gas exchange occurs at the alveolar-capillary membrane. 3 phases: 1. Ventilation - movement of air from the atmosphere through the upper & lower airways to the alveoli 2. Perfusion - blood from the pulmonary circulation is adequate at the alveolar-capillary bed 3. Diffusion - molecules move from area of higher concentration to lower concentration of gases - O2 passes into the capillary bed to be circulated & CO2 leaves the capillary bed & diffuses into the alveoli for vent. excretion
  • 4. Respiratory Tract • Perfusion - influenced by alveolar pressure. For gas exchange, the perfusion of each alveoli must be matched by adequate ventilation. Mucosal edema, secretions, & bronchospasms increase the resistance to airflow & dec. ventilation & diffusion of gases • Bronchial Smooth Muscle - In the tracheobronchial tube is smooth muscle whose fibers spiral around the tube  contraction  constriction of airway - Parasympathetic Nervous system  releases acetylcholine  bronchoconstriction - Sympathetic Nervous system  releases epinephrine  stimulates beta-2 receptors in bronchial smooth muscle  bronchodilation
  • 5. Drugs for Upper respiratory Infections • Upper Respiratory Infections (URI’s) = common cold, acute rhinitis, sinusitis, acute tonsillitis, acute laryngitis - The common cold = most expensive > $500 million spent on OTC preparations • Common Cold & Acute Rhinitis - - Common cold caused by the rhinovirus & affects primarily the nasopharyngeal tract. - Acute rhinitis (inflammation of mucus membranes of nose) usually accompanies the common cold - Allergic rhinitis - caused by pollen or a foreign substance
  • 6. Drugs for Upper Respiratory Infections • Incubation period of a cold = 1 to 4 days before onset of symptoms & first 3 days of the cold - Home remedies = rest, chicken soup, hot toddies, Vitamins - 4 groups of drugs used to manage symptoms = antihistamins (H-1 blocker), decongestants (sympathomimetic amines), antitussives, expectorants
  • 7. Drugs for Upper Respiratory Infections - Antihistamines • Antihistamines or H-1 blockers - compete w/ histamine for receptor sites  prevents a histamine response. 2 types of histamine receptors - H-1 & H-2 H-1 stimulation = extravascular smooth muscles (including those lining nasal cavity) are constricted H-2 stimulation = an inc. in gastric secretions = peptic ulcer disease Do not confuse the 2 receptors - antihistamines decrease nasopharyngeal secretions by blocking the H-1 receptor
  • 8. Drugs for Upper Respiratory Infections - antihistamines • Histamines - A compound derived from an amino acid histadine. Released in response to an allergic rxn (antigen- antibody rxn) - such as inhaled pollen - When released it reacts w/ H-1 receptors = arterioles & capillaries dialate = inc. in bld flow to the area = capillaries become more permeable = outward passage of fluids into extracellular spaces= edema (congestion) = release of secretions (runny nose & watery eyes) - Large amts. of released histamine in an allergic rxn = extensive arteriolar dilation = dec. BP, skin flushed & edematous = itching, constriction & spasm of bronchioles = SOB & lg. amts. of pulmonary & gastric secretions
  • 9. Drugs for Upper Respiratory Infections - Antihistamines • Astemizole (Hismanal), Cetirizine (Zertec), Loratadine (Claritin), Chlorpheniramine (Chlortrimeton), Diphenhydramine (Benadryl) • Actions = competitive antagonist at the histamine receptor; some also have anticholinergic properties • Uses = Treat colds; perennial/seasonal allergic rhinitis (sneezing, runny nose); allergic activity (drying & sedation); some are also antiemetic • SE = Drowsiness, dizziness, sedation, drying effects • CI = glaucoma, acute asthma
  • 10. Drugs for Upper Respiratory Infections - Decongestants • Nasal congestion results from dilation of nasal bld. vessels d/t infection, inflammation, or allergy. With dilation there’s transudation of fluid into tissue spaces  swelling of the nasal cavity • Decongestants (sympathomimetic amines) - stimulate alpha-adrenergic receptor  vasoconstriction of capillaries w/in nasal mucosa  shrinking of the nasal mucus membranes & reduction in fluid secretion (runny nose)
  • 11. Drugs for Upper Respiratory Infections - Decongestants • Naphazoline HCL (Allerest), Pseudoephedrine (Actifed, Sudafed), Oxymetolazone (Afrin), Phenylpropanolamine HCL (Allerest, Dimetapp) • Use - Congestion d/t common cold, hayfever, upper resp. allergies, sinusitis • SE = Jittery,nervous,restless, Inc BP, inc. bld. sugar • CI = Hypertension, cardiac disease, diabetes • Preparations = nasal spray, tablets, capsules, or liquid • Frequent use, esp. nasal spray, can result in tolerance & rebound nasal congestion - d/t irritation of nasal mucosa
  • 12. Drugs for Upper Respiratory Infections - Intranasal Glucocorticoids • Beclomethasone (Beconase, Vancenase, Vanceril), Budesonide (Rhinocort), Dexamethasone (Decadron)fluticasone (Flonase) - Action - steroids used to dec. inflammation locally in the nose - Use - Perennial/seasonal allergic rhinitis (sneezing, runny nose) - May be used alone or w/ antihistamines - SE - rare, but w/ continuous use dryness of the nasal mucosa may occur
  • 13. Drugs for Upper Respiratory Infections - Antitussives • Action - Acts on the cough control center in the medulla to suppress the cough reflex • Use - Cough suppression for non-productive irritating coughs * Codeine - Narcotic analgesic to control a cough d/t the common cold or bronchitis * Dextromethorphan - nonnarcotic antitussive that suppresses the cough center in the medulla, widely used - syrup, liquid, chewable & lozenges - SE = drowsiness, sedation
  • 14. Drugs for Upper Respiratory infections - Expectorants • Action - Loosens bronchial secretions so they can be eliminated w/ coughing * A nonproductive cough becomes more productive and less frequent • Uses - Nonproductive coughs • Guaifenesin (Robitussin) = Most common * Use alone or in combo w/ other resp. drugs • Hydration is the best expectorant
  • 15. Chapter 36 Drugs for Acute and Chronic Lower Respiratory Disorders
  • 16. Drugs for Lower Respiratory Disorders • Lung Compliance - Lung volume based on the unit of pressure in the alveoli * Determines the lung’s ability to stretch (tissue elasticity) * Determined by: connective tissue; surface tension in the alveoli controlled by surfactant - surfactant lowers surface tension in alveoli & prevents interstitial fluid from entering * Inc. (high) lung compliance in COPD * Dec. (low) lung compliance in restrictive pulmonary disease = lungs become “stiff” & need more pressure
  • 17. Drugs for Lower Respiratory Disorders • Chronic obstructed pulmonary disease (COPD) & restrictive pulmonary disease = 2 major lower resp. tract diseases • COPD = airway obstruction w/ inc. airway resistance to airflow to lung tissues - 4 causes - Chronic bronchitis - emphysema - Bronchiectasis - asthma * Above frequently result in irreversible lung tissue damage. Asthma reversible unless frequent attacks and becomes chronic.
  • 18. Drugs for Lower Respiratory Disorders • Restrictive lung disease = a dec. in total lung capacity as a result of fluid accumulation or loss of elasticity of the lung. * Causes: Pulmonary edema, pulmonary fibrosis, pneumonitis, lung tumors, scoliosis • Bronchial Asthma = 10-12 million people of all ages affected - a chronic obstructive pulmonary disease characterized by periods of bronchospasm resulting in wheezing & difficulty in breathing
  • 19. Drugs for Lower Respiratory Disorders • Asthma - Bronchospasm or bronchoconstriction results when the lung tissue is exposed to extrinsic or intrinsic factors that stimulate a bronchoconstrictive response - Causes: humidity, air pressure changes, temp. changes, smoke, fumes, stress, emotional upset, allergies, dust, food, some drugs * Pathophys = Mast cells (found in connective tissue throughout the body) are directly involved in the asthmatic response - esp. to extrinsic factors - allergens attach themselves to mast cells & basophils = antigen-antibody rxn
  • 20. Drugs for Lower Respiratory Disorders - Asthma • Mast cells stimulate release of chemical mediators (histamines, cytokines, serotonin, ECF-A (eosinophils)) • These chemical mediators stimulate bronchial constriction, mucous secretions, inflammation, pulmonary congestion • Cyclic adenosine monophosphate (cAMP) - a cellular substance responsible for maintaining bronchodilation - When inhibited by histamines & ECF-A  bronchoconst. • Sympathomimetic (adrenergic) bronchodilators inc. amt. of cAMP & promote dilation  first line drugs used
  • 21. Drugs for Lower Respiratory Disorders • Sympathomimetics: Alpha & Beta-2 Adrenergic Agonists • Increase cAMP  dilation of bronchioles in acute bronchospasm caused by anaphylaxis from allergic rxn give nonselective epinephrine (Adrenalin) - SQ in an emergency to promote bronchodilation & inc. BP SE = tremors, dizziness, HTN, tachycardia, heart palpitations, angina • For bronchospasm d/t COPD - selective beta-2 adrenergic agonists are given via aerosol or tablet
  • 22. Drugs for Lower Respiratory Disorders • Metaproterenol (Alupent, Metaprel) - some beta-1, but primarily used as a beta-2 agent - PO or inhaler/nebulizer - For long-term asthma Rx beta-2 adrenergic agonists frequently given by inhalation * more drug delivered directly to constricted bronchial site * Effective dose less than PO dose & less side effects - Action = relaxes bronchial smooth muscle - onset = fast - SE = Nervousness, tremors, restlessness, insomnia & inc. HR
  • 23. Drugs for Lower Respiratory Disorders • Albuterol (Proventil, Ventolin) - More beta-2 selective - PO or inhaler - Used for acute/chronic asthma - Rapid onset of action & longer duration than Metaproterenol - Fewer SE because more beta-2 specific, but high doses can still effect beta-1 receptors & cause nervousness, tremors & inc. pulse rate
  • 24. Drugs for Lower Respiratory Disorders - Anticholinergics • Ipratropium bromide (Atrovent) - - Action - competitive antagonist (inhibits) of cholinergic receptors in bronchial smooth muscle = bronchiole dilation - Inhaler - Use - In combination w/ beta agonist for asthma & for bronchospasm associated w/ COPD - Need to teach clients how to use properly: If using Atrovent w/ a beta-agonist, use beta-agonist 5 min. before Atrovent; If using Atrovent w/ an inhaled steroid or cromolyn, use Atrovent 5 min. before the steroid or cromolyn - bronchioles dilate & drugs more effective
  • 25. Drugs for Lower Respiratory Disorders - Methylxanthine derivatives • Aminophylline, Theophylline (TheoDur), Caffeine – * PO or IV - * Use - Treatment of asthma & COPD * Action - Inc. cAMP  bronchodilation; also - diuresis, cardiac, CNS & gastric acid stimulation * When given IV  a low therapeutic index & range - Monitor levels frequently * PO doses can be given in standard dosages * Avoid smoking, caffeine & inc. fluid intake
  • 26. Methylxanthine derivatives • Drug Interactions: Inc the risk of dig toxicity, decreases the effects to lithium,dec theophyllin levels with Dilantin, theophyllin and beta-adrenergic agonist given together - synergistic effect can occurcardiac dysrhythmias. Beta blockers, Tagamet, Inderal and e-mycin decrease the liver metabolism rate and inc. the half-life and effects of theophyllin • SE : Anorexia, N&V, nervousness, dizziness, palpitations, GI upset & bleeding, HA, restlessness, flushing, irritability, marked hypotension, hyper-reflexia and seizures. • CI: Severe cardiac dysrhythmias, hyperthyroidism, peptic ulcer disease (increases gastric secretions)
  • 27. Drugs for Lower Respiratory Disorders - Leukotrine Receptor Antagonists & Synthesis Inhibitors • Leukotriene (LT) a chemical mediator that can cause inflammatory changes in the lung. The group cysteinyl leukotrienes promotes and inc in eosinophil migration, mucus production, and airway wall edema, which result in broncho-constriction. • LT receptor antagonists & LT synthesis inhibitors (Leukotriene modifiers) effective in reducing the inflammatory symptoms of asthma triggered by allergic & environmental stimuli - Not for acute asthma
  • 28. Leucotriene receptor antagonist and synthesis inhibitors •Zafirlukast (Accolate), Zileuton (Zyflo), Montelukast sodium (Singulair) – PO • Action - Decreases the inflammatory process Use - prophylactic & maintenance drug therapy for asthma •Accolate – 1st in group, leukotriene receptor antagonist reduce inflammation & dec bronchoconstriction, PO- BID-rapidly absorbed •Singulair –New leukotriene receptor antagonist, short t1/2 (2.5-5.5) Safe for children under 6yo.
  • 29. Drugs for Lower Respiratory Disorders - Glucocorticoids (Steroids) • Glococorticoids have an anti-inflammatory action and are used if asthma is unresponsive to bronchodilator therapy • Given: inhaler- beclomethasone (Vanceril, Beclovent); tablet - triamcinolone (Amcort, Aristocory), dexamethasone (Decadron), prednisone; injection - dexamethasone, hydrocortisone • SE significant w/ long-term oral use - fluid retention, hyperglycemia, impaired immune response • Irritating to the gastric mucosa - take w/ food • When d/c’ing taper the dosage slowly
  • 30. Drugs for Lower Respiratory Disorders - Cromolyn & Nedocromil • Cromolyn (Intal) - for prophylactic Rx of bronchial asthma & must be taken on a daily basis - NOT used for acute asthma - Inhaler * Action - inhibits the release of histamine that can cause an asthma rxn * SE - mouth irritation, cough & a bad taste in the mouth ** Caution - rebound bronchospasm is a serious side effect do not d/c the drug abruptly • Nedocromil sodium - action & uses similar to Intal - prophylactic usage - inhalation therapy - may be more effective than Intal
  • 31. Drugs for Lower Respiratory Disorders - Mucolytics • Acetylcysteine (Mucomyst) - nebulization * Action - liquefies & loosens thick mucous secretions so they can be expectorated * Use - dissolves thick mucous, acetaminophen overdose (bonds chemically to reduce liver damage) * SE - N & V, chest tightness, bronchoconstriction * Use w/ a bronchodilator • Dornase alfa (Pulmozyme) - an enzyme that digests the DNA in thick sputum of cystic fibrosis (CF) clients
  • 32. MATH NDC 000w-7293-01 VIAL No. 7293 R/X Lilly ADD-Vantage Vial NEBCIN Tobramycin sulfate injection, usp 60 Mg per 6ml You need to prepare 30 mg. How much solution will you need? 30 mg X 6 ml = 60 mg 1 X 6 ml = 2 6 = 3 ml 2